Provider: Nature Publishing Group Content: application/x-research-info-systems TY - JOUR AU - Kerbel, R. S. AU - Kamen, B. A. TI - The anti-angiogenic basis of metronomic chemotherapy JO - Nature Rev. Cancer PY - 2004/// VL - 4 SP - 423 EP - 436 M3 - 10.1038/nrc1369 N1 - 10.1038/nrc1369 UR - http://dx.doi.org/10.1038/nrc1369 ER - TY - JOUR AU - Semenza, G. L. TI - Surviving ischemia: adaptive responses mediated by hypoxia-inducible factor 1 JO - J. Clin. Invest. PY - 2000/// VL - 106 SP - 809 EP - 812 ER - TY - JOUR AU - Tran, J. TI - A role for survivin in chemoresistance of endothelial cells mediated by VEGF JO - Proc. Natl Acad. Sci. USA PY - 2002/// VL - 99 SP - 4349 EP - 4354 M3 - 10.1073/pnas.072586399 N1 - 10.1073/pnas.072586399 UR - http://dx.doi.org/10.1073/pnas.072586399 ER - TY - JOUR AU - Yu, J. L. AU - Rak, J. W. AU - Coomber, B. L. AU - Hicklin, D. J. AU - Kerbel, R. S. TI - Effect of p53 status on tumour response to antiangiogenic therapy JO - Science PY - 2002/// VL - 295 SP - 1526 EP - 1528 M3 - 10.1126/SCIENCE.1068327 N1 - 10.1126/SCIENCE.1068327 UR - http://dx.doi.org/10.1126/SCIENCE.1068327 ER - TY - JOUR AU - Blagosklonny, M. V. TI - Antiangiogenic therapy and tumour progression JO - Cancer Cell PY - 2004/// VL - 5 SP - 13 EP - 17 M3 - 10.1016/S1535-6108(03)00336-2 N1 - 10.1016/S1535-6108(03)00336-2 UR - http://dx.doi.org/10.1016/S1535-6108(03)00336-2 ER - TY - JOUR AU - Pennacchietti, S. TI - Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene JO - Cancer Cell PY - 2003/// VL - 3 SP - 347 EP - 361 M3 - 10.1016/S1535-6108(03)00085-0 N1 - 10.1016/S1535-6108(03)00085-0 UR - http://dx.doi.org/10.1016/S1535-6108(03)00085-0 ER - TY - JOUR AU - Rofstad, E. K. TI - Hypoxia promotes lymph node metastasis in human melanoma xenografts by up-regulating the urokinase-type plasminogen activator receptor JO - Cancer Res. PY - 2002/// VL - 62 SP - 1847 EP - 1853 ER - TY - JOUR AU - Kieran, M. W. AU - Folkman, J. AU - Heymach, J. TI - Angiogenesis inhibitors and hypoxia JO - Nature Med. PY - 2003/// VL - 9 SP - 1104 EP - 1104 M3 - 10.1038/nm0903-1104a N1 - 10.1038/nm0903-1104a UR - http://dx.doi.org/10.1038/nm0903-1104a ER - TY - JOUR AU - Kerbel, R. AU - Folkman, J. TI - Clinical translation of angiogenesis inhibitors JO - Nature Rev. Cancer PY - 2002/// VL - 2 SP - 727 EP - 739 M3 - 10.1038/nrc905 N1 - 10.1038/nrc905 UR - http://dx.doi.org/10.1038/nrc905 ER - TY - GEN AU - Chabner, B. A. TI - Goodman and Gilman's The Pharmacological Basis of Therapeutics PY - 1996/// ER - TY - JOUR AU - Tozer, G. M. AU - Kanthou, C. AU - Parkins, C. S. AU - Hill, S. A. TI - The biology of the combretastatins as tumour vascular targeting agents JO - Int. J. Exp. Pathol. PY - 2002/// VL - 83 SP - 21 EP - 38 M3 - 10.1046/j.1365-2613.2002.00211.x N1 - 10.1046/j.1365-2613.2002.00211.x UR - http://dx.doi.org/10.1046/j.1365-2613.2002.00211.x ER - TY - JOUR AU - Miklos, A. G. AU - Lyman, M. D. AU - Freed, L. E. AU - Langer, R. TI - Wetting of poly(L-lactic acid) and poly(D-lactic-co-glycolic acid) foams for tissue culture JO - Biomaterials PY - 1994/// VL - 15 SP - 55 EP - 58 ER - TY - JOUR AU - Yoo, H. S. AU - Oh, J. E. AU - Lee, K. H. AU - Park, T. G. TI - Biodegradable nanoparticles containing doxorubicin-PLGA conjugate for sustained release JO - Pharm. Res. PY - 1999/// VL - 16 SP - 1114 EP - 1118 M3 - 10.1023/A:1018908421434 N1 - 10.1023/A:1018908421434 UR - http://dx.doi.org/10.1023/A:1018908421434 ER - TY - JOUR AU - Sengupta, S. AU - Kiziltepe, T. AU - Sasisekharan, R. TI - A dual-colour fluorescence imaging-based system for the dissection of antiangiogenic and chemotherapeutic activity of molecules JO - FASEB J. PY - 2004/// VL - 18 SP - 1565 EP - 1567 ER - TY - JOUR AU - Jain, R. K. TI - Normalizing tumour vasculature with anti-angiogenic therapy: a new paradigm for combination therapy JO - Nature Med. PY - 2001/// VL - 7 SP - 987 EP - 989 M3 - 10.1038/nm0901-987 N1 - 10.1038/nm0901-987 UR - http://dx.doi.org/10.1038/nm0901-987 ER - TY - JOUR AU - Hanahan, D. AU - Bergers, G. AU - Bergsland, E. TI - Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumour angiogenesis in mice JO - J. Clin. Invest. PY - 2000/// VL - 105 SP - 1045 EP - 1047 ER - TY - JOUR AU - Allen, T. M. TI - Ligand-targeted therapeutics in anticancer therapy JO - Nature Rev. Drug Discov. PY - 2002/// VL - 2 SP - 750 EP - 763 M3 - 10.1038/nrc903 N1 - 10.1038/nrc903 UR - http://dx.doi.org/10.1038/nrc903 ER - TY - JOUR AU - Yuan, F. TI - Vascular permeability in a human tumour xenograft: molecular size dependence and cutoff size JO - Cancer Res. PY - 1995/// VL - 55 SP - 3752 EP - 3756 ER - TY - JOUR AU - Tong, R. T. TI - Vascular normalization by vascular endothelial growth facor receptor-2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors JO - Cancer Res. PY - 2004/// VL - 64 SP - 3731 EP - 3736 ER - TY - JOUR AU - Arap, W. TI - Steps toward mapping the human vasculature by phage display JO - Nature Med. PY - 2002/// VL - 8 SP - 121 EP - 127 M3 - 10.1038/nm0202-121 N1 - 10.1038/nm0202-121 UR - http://dx.doi.org/10.1038/nm0202-121 ER - TY - JOUR AU - Hanahan, D. AU - Weinberg, R. A. TI - The hallmarks of cancer JO - Cell PY - 2000/// VL - 100 SP - 57 EP - 70 M3 - 10.1016/S0092-8674(00)81683-9 N1 - 10.1016/S0092-8674(00)81683-9 UR - http://dx.doi.org/10.1016/S0092-8674(00)81683-9 ER -